The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma
Clinical Cancer Research (2010) - Comments
pubmed: 20606035  doi: 10.1158/1078-0432.ccr-09-3022  issn: 1078-0432  issn: 1557-3265 

Daniel C. Cho, Matthew B. Cohen, David J. Panka, Michael Collins, Musie Ghebremichael, Michael B. Atkins, Sabina Signoretti, James W. Mier